Can anyone answer these 3 basic question:-
(1) How does a private patient afford to pay $25,000 US dollars for one single dose of the Oncosil device?
(2) Will a health insurance fund provide insurance for the Oncosil device in Europe following the CE Mark approval?
(3) Will the government health authority such as the NHS in the UK provide financial reimbursement for the Oncosil device?
Appreciate any constructive thoughts on these questions.
Ann: OncoSil receives Swiss regulatory approval, page-30
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.99M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $3.293K | 720.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 23973265 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 9017803 | 9 |
View Market Depth
| Last trade - 13.28pm 27/06/2024 (20 minute delay) ? |
| OSL (ASX) Chart |